glp 1 and hormone replacement therapy Who Should Explore GLP-1 Shots from BodyLogicMD? GLP-1 for Weight Loss and

Head-to-head GI comparison table The pattern is clear

3C), 12 mg/kg (FIG

Second, although there is abundant evidence from basic research, there is still a significant evidence gap in clinical trials targeting populations, lacking large sample size data to support efficacy and safety

The current evidence base primarily from animal studies and limited human trials suggests the following potential applications: Improved sleep quality increased proportion of slow-wave sleep, reduced sleep latency, fewer nocturnal cortisol spikes Cortisol normalisation reduced HPA hyperactivation, particularly relevant in high-stress or metabolically burdened patients Nociceptive effects several studies indicate DSIP modulates pain processing, with implications for patients whose poor sleep is pain-driven (3) Antioxidant activity may reduce oxidative stress markers, which are elevated in both sleep-deprived and insulin-resistant individuals Neuroendocrine support preliminary evidence of effects on LH, FSH, and somatostatin hormones that regulate testosterone, oestrogen, and growth hormone release Potential stress adaptation some data suggest DSIP may reduce the physiological stress response magnitude without blunting alertness It is important to be precise here

labels warn of vision changes without mentioning NAION